PDF-Cardioversion

Definition Cardioversion is a method to restore an abnormal heart rhythm back to normal Information Cardioversion can be done using an energy shock electric cardioversion or medications pharmac. pathophysiology. and medical management. Dipin.S. Junior resident. medicine. Supraventricular. . tachy. . arrythmia. . charecterised. by uncoordinated . atrial. activation and consequent deterioration of . By: Martin Grant. Student no. 40077467. Cardioversion is defined as a “. synchronised direct current (DC) . discharge, and … does not apply to ventricular defibrillation or to the pharmacologic reversion of arrhythmias. Department of Anesthesiology . Imam Reza Hospita. l. Rhythms for unstable tachycardia. Sinus tachycardia. Atrial. fibrillation. Atrial. flutter. Reentry . supraventricular. tachycardia (SVT). Monomorphic. Why Anticoagulate?. Anticoagulate Even in High-Risk Patients ?. Efficacy and Safety of NOACs vs Warfarin in NVAF by Age. Efficacy and Safety of Edoxaban . vs Warfarin by Age in ENGAGE AF-TIMI 48. Efficacy and Safety of NOACs vs Warfarin in the ≥75 Age Group. Overview . Definition and epidemiology. Symptoms. Tests/Evaluations. Complications. Treatment. Effects on exercise. Medications effect on exercise. Effects of training. Exercise prescription. Definition. 2. Arrhythmia. Unstable :. Altered mental status. Ischemic chest discomfort. Acute heart failure. Hypotension . Other signs of shock. Symptomatic:. Palpitations. Lightheadedness. Dyspnea. 07/07/1392. Overview . Definition and epidemiology. Symptoms. Tests/Evaluations. Complications. Treatment. Effects on exercise. Medications effect on exercise. Effects of training. Exercise prescription. Definition. <1% of individuals aged 60 to 65 years . 8% to 10% of individuals aged >80 years . Men more than women . White persons more than black persons. Presence and severity of underlying heart disease increases risk . Cardiac . electrical activity can be monitored by using . ECG; . a . resting, ambulatory (. Holter. . monitoring), continuous cardiac monitoring, or . by telemetry. Cardiac dysrhythmias are heartbeat disturbances (beat formation, . Dr . Sura. Al . Zoubi. PhD,. MClinPharm. Lecture 7. 1. Pharmacotherapy: A Pathophysiologic Approach, . 10e. . Chapter 18: The . Arrhythmias. 2014 . AHA/ACC/HRS . Guideline for . the Management of . Patients With . sami. Defibrillators. Defibrillator: is a device that deliver a therapeutic dose of electrical energy (electric shock) to the affected heart (heart with fibrillation) to force the heart to produce normal cardiac rhythm. . rivaroxaban. group vs. 1.02% of the vitamin K antagonist group (p = . NS). Major bleeding: 0.61% of the . rivaroxaban. group vs. 0.80% of the placebo group (p = . NS). Trial design:. . Participants with . M.A . Akbarzadeh. MD. Assistant . professor of . Electrophysiology Shahid . Beheshti. university of medical sciences. Modarres. Hospital. Aug 2016. New . Oral Anticoagulants. Practical Approach. Case 1. Seda Yılmaz-Semerci 1 , Helen Bornaun 2 , Dilek Kurnaz 1 , Burcu Cebeci 1 , Aslan Babayigit 1 , Gökhan Büyükkale 1 , Merih Çetinkaya 1 Division of 1 Neonatology and 2 Pediatric Cardiology, Dep